Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Jun 16 2021

Normal Bone Metabolism

  • Introduction
    • Normal bone metabolism is the complex sequence of bone turnover (osteoclastogenesis) and bone formation (osteoblastogenesis)
      • Physiology of bone metabolism
        • bone has structural and metabolic functions
        • metabolic functions of bone largely involve the homeostasis of calcium and phosphate
        • release of calcium, or absorption of calcium, by bone is largely regulated by hormones and, less so, by steroids
  • Calcium
    • Location
      • bone (99%)
      • blood and extracellular fluid (0.1%)
      • intracellular (1%)
    • Function
      • calcium has a wide range of function including
        • muscle cell contraction
        • nerve conduction
        • clotting mechanisms
    • Forms of calcium
      • bone
        • majority is hydroxyapatite
      • serum
        • Ca++ bound to protein (45%)
        • free-ionized Ca++ (45%)
        • bound to various anions, eg. citrate, bicarbonate (10%)
    • Regulation
      • absorption from the digestive tract
      • resorption from bone
      • resorption in the kidneys
    • Dietary requirements
      • 2000 mg/day for lactating women
      • 1500 mg/day for pregnant women, postmenopausal woman, and patients with a healing bone fracture
      • 1300 mg/day for adolescents and young adults
      • 750 mg/day for adults
      • 600 mg/day for children
    • Dysfunction
      • hypercalcemia
      • hypocalcemia
  • Phosphate
    • Location
      • bone (86%)
      • blood and extracelluar fluid (0.08%)
      • intracellular (14%)
    • Function
      • key component of bone mineral
      • important in enzyme systems and molecular interactions
    • Forms of phosphate
      • bone
        • majority is hydroxyapatite
      • serum
        • mostly inorganic phosphate (H2PO4-)
    • Regulation
      • plasma phosphate is mostly unbound and reabsorbed by the kidney
      • may be excreted in urine
      • elevated serum phosphate can lead to increased release of PTH and bone resorption
    • Dietary intake
      • 1000-1500 mg/day
  • PTH
    • Structure
      • 84 amino acid peptide
    • Origin
      • synthesized and secreted from chief cells in the four parathyroid glands
    • Net effect
      • increases serum calcium
      • decreases serum phosphate
    • Mechanism
      • bone
        • PTH stimulates osteoblasts to secrete IL-1, IL-6 and other cytokines to activate osteoclasts and increase resorption of bone
        • Increases osteoblast production of M-CSF (macrophage colony-stimulating factor) and RANKL, which increases number of osteoclasts.
        • Paradoxically, osteoclasts do not express receptor for PTH
      • kidney
        • stimulates enzymatic conversion of 25-(OH)-vitamin D3 converted to 1,25-(OH)2-vitamin D3 (active hormone form) which:
      • intestine
        • no direct action
        • indirectly increase Ca++ absorption by activating 1,25-(OH)2-vitamin D3
    • Dysfunction
      • PTH-related protein and its receptor have been implicated in metaphyseal dysplasia
    • Parathyroid hormone-related protein (PTHrP) has related effects to PTH as it binds to the same receptors on osteoblasts and renal cells to increase serum calcium
  • Calcitonin
    • Structure
      • 32 amino-acid peptide hormone
    • Origin
      • produced by clear cells in the parafollicles of the thyroid gland (C cells)
    • Net effect
      • limited role in calcium homeostasis
      • inhibit number and activity of osteoclasts
    • Function
      • bone
        • inhibits osteoclastic bone resorption by decreasing number and activity of osteoclasts
        • osteoclast have receptor for calcitonin
        • Inc. serum Ca > secretion of calcitonin > inhibition of osteoclasts > dec. Ca (transiently)
      • Dysfunction
        • secreted by medullary thyroid tumors and mulitple endocrine neoplasia type II tumors
        • Recombinant calcitonin used to treat Paget disease, osteoporosis, and hypercalcemia in malignancy
  • Vitamin D
    • Structure
      • fat soluble secosteroid (steroid with a 'broken ring')
    • Origin
      • produced by skin when exposed to sunlight (UV B-generated Vitamin D)
      • dietary intake (lipid-soluble vitamin D3)
      • active metabolite 1,25-(OH)2-vitamin D3 formed by two hydroxylations in the liver and kidney, respectively
    • Net effect
      • maintains normal serum calcium levels by activating osteoclasts for bone resorption and increasing intestinal absorption of calcium (increase serum Ca++)
      • promotes the mineralization of osteoid matrix
    • Function
      • liver
        • activated-vitamin D3 converted to 25-(OH)-vitamin D3
      • kidney
        • vitamin D parallels that of PTH by increasing reabsorption of Ca in the kidneys
      • bone
        • 1,25-(OH)2-vitamin D3 stimulates terminal differentiation of osteoclasts
        • when osteoclasts mature they do not respond to 1,25-(OH)2-vitamin D3 and respond mostly to cytokines released by osteoblasts
        • 1,25-(OH)2-vitamin D3 promotes the mineralization of osteoid matrix produced by osteoblasts
    • Dysfunction
      • Vitamin D deficiency causes osteomalacia and rickets
      • phenytoin (dilantin) causes impaired metabolism of vitamin D
  • Estrogen
    • Structure
      • D ring steroid hormone
    • Origin
      • predominantly in the ovaries
      • synthetic forms available
    • Net effect
      • prevents bone loss by decreasing the frequency of bone resorption and remodeling
    • Function
      • alone, because bone formation and resorption are coupled, it also indirectly decreases bone formation
      • leads to an increase in bone density of the femoral neck and reduces the risk of hip fracture
      • most important sex-steroid for peak bone mass attainment in both men and women
    • Therapeutic estrogen
      • outcomes
        • decreases bone loss if started within 5-10 years after onset of menopause
        • significant side effects so risk/benefit ratio must be evaluated
        • gains in bone mass usually limited to an annual increase of 2-4% for the first 2 years of therapy
  • Growth Hormone
    • Function
      • increases serum calcium by
        • increased absorption in intestine
        • decreasing urinary excretion
      • function is interdependent with insulin, somatomedins, and growth factors (TGF-B, PDGF, mono/lyphokines)
    • Gigantism
      • oversecretion or increased response to growth hormone effecting the proliferative zone of the growth plate
  • Thyroid Hormone
    • Function
      • regulates skeletal growth at the physis by stimulating
        • chondrocyte growth
        • type X collagen synthesis
        • alkaline phosphatase activity
      • thyroid hormones increase bone resorption and can lead to osteoporosis
        • large doses of therapeutic thyroxine can mimic this process and cause osteoporosis
  • Steroids
    • Function
      • increase bone loss by
        • decreasing Ca++ absorption in intestine through a decrease in binding proteins
flashcard locked
Create a free account or log in to see the cards.
Question
1 of 4
Basic Science⎪Normal Bone Metabolism
  • Basic Science
  • - Normal Bone Metabolism
16:57 min
7/3/2020
818 plays
5.0
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
(3)
Private Note